Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $629.44, with a ...

Bernstein lowered the firm’s price target on Thermo Fisher (TMO) to $585 from $690 and keeps an Outperform rating on the shares. With tariffs, ...

Baird lowered the firm’s price target on Thermo Fisher (TMO) to $603 from $660 and keeps an Outperform rating on the shares. The firm updated ...

Thermo Fisher Scientific (NYSE:TMO) recently launched its 5L DynaDrive Single-Use Bioreactor, enhancing their offerings in bioprocessing. This announcement, coupled with their collaboration with NSG ...

Veteran investor Ken Fisher joins the growing list of billionaires who have criticized President Donald Trump's aggressive ...

We recently published a list of Top 12 Tech Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going ...

We estimate Fisher has over 70% market share in the hospital setting ... net debt/net debt plus equity of negative 2.9%, within the target range of negative 5% to positive 5%.

Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.

Fisher Investments Canada’s reviews of market history differ ... oriented companies tend to take leadership as investors target the high-quality characteristics they commonly feature, including ...

Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a ...

The crypto market didn’t get a respite from the ongoing ... Now, another billionaire investor has slammed Trump’s tariff war. Ken Fisher, the billionaire founder and executive chairman of ...

The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching ...